Jonathan has 15 years’ experience in the pharmaceutical industry developing innovative products and brands for prescriptive nutritional markets. He acquired recombinant human Intrinsic Factor technology from the University of Aarhus, Denmark in 2011 and founded Xeragenx LLC to commercialize this unique platform. Jonathan obtained his medical degree from the University of the Witwatersrand Medical School in South Africa and did his fellowship in Endocrinology at Washington University in St. Louis, MO.
Eric has more than 30 years’ pharmaceutical industry experience in manufacturing and operations leadership, project management and new product commercialization. Eric joined Xeragenx in 2013 and built the supply chain from which to successfully grow the genetically transformed Arabidopsis plant extraction of recombinant human Intrinsic Factor (rh-IF). Eric earned his BS in Marketing and MBA in Management/Strategic Planning from the Wharton School of the University of Pennsylvania.
